In the BioHarmony Drug Report Database
Emtriva (emtricitabine) is a small molecule pharmaceutical. Emtricitabine was first approved as Emtriva on 2003-07-02. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Emtriva’s patent is valid until 2021-03-09 (FDA).
Image (chem structure or protein)